supplied by www.ccc.ac.at

4 Einträge

Therapeutic management of metastatic breast cancer across Europe: European observatory and survey (EOS).
Autoren Krzemieniecki K, Antolín Novoa S, Gozy M, Schumacher C, Steger GG, Carteni' G, Bird BR, Albuisson E, Barnadas A, Batist G, De Mouzon J, Erdkamp F, Leonard RC, Lueck H, Namer M, Venturini M, Ronga P, Maumus-Robert S, Aapro MS
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e11556
Publikations ID PMID: 28021699
 


Characterization of patients who received prior chemotherapy for advanced breast cancer (ABC) in BOLERO-2.
Autoren Campone M, Lebrun F, Noguchi S, Pritchard KI, Burris HA, Beck JT, Ito Y, Bachelot T, Pistilli B, Melichar B, Petrakova K, Arena FP, Erdkamp F, Harb WA, Litton JK, Brechenmacher T, El-Hashimy M, Taran T, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.151
Publikations ID PMID: 28136563
 


396PUSE OF LIPOSOMAL DOXORUBICIN FOR METASTATIC BREAST CANCER MANAGEMENT ACROSS EUROPE: RESULTS OF EOS (EUROPEAN OBSERVATORY & SURVEY).
Autoren Lorusso V, Śmiałowska-Janiszewska A, Krzemieniecki K, Novoa SA, Mefti F, Janssen J, Steger GG, Bird B, Turazza M, Yosef H, Albuisson E, Barnadas A, Batist G, De Mouzon J, Erdkamp F, Leonard R, Namer M, Maumus-Robert S, Aapro MS
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241140. doi: 10.1093/annonc/mdu329.45
Publikations ID PMID: 28170758
 


Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Autoren Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A
Erscheinungsdaten The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9
Publikations ID PMID: 29146401